Allergy POC analyzer NOVEOS

bloodsurfaceclinical

NOVEOS not only runs more allergy tests and more follow-up tests per tube, it also reduces additional blood draws. The small sample volume also reduces the need for test prioritization by clinicians and laboratorians. Testing for more allergens using less sample benefits patients and labs. It may seem small, but for pediatric patients and their families, it’s a major upgrade. How Reliable are YOUR Allergy Results? G etting the right results matters to make reliable clinical decisions. The NOVEOS innovative assay design helps overcome interference and produces accurate allergy test results. Biotin interference occurs in many existing assay designs. This results in FALSELY LOW values providing confusing or misleading results to physicians and patients. Samples containing cross-reactive carbohydrate determinant (CCD) structures tend to produce FALSELY HIGH results, particularly when using cellulose-based technologies. The assay design of NOVEOS is unaffected by biotin or cellulose-based CCD interference. The small sample volume per test leads to less interference from serum-based substances. The microparticle approach gives a dramatic increase in surface area leading to superb sensitivity NOVEOS Improves YOUR Lab Workflow With a high level of automation, there’s no need for intervention during a run. The instrument offers a true walk-away capability of up to 13 hours when plumbed to in-house systems. By reducing hands-on time and overhead, your lab saves operational costs, enabling technicians to focus on other activities.